Clinical Trials Browser

OTHER_GOV × Cyclophosphamide × Other hematologic neoplasm × Clear all

Leukemia

NCT06299462 2025-02-25

PTCy and ATG for MSD and MUD Transplants

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05477589 2024-12-19

SCRIPT-AML

Phase 3 Recruiting

170 enrolled

Other hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myeloid, Acute

NCT05528887 2022-09-06

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Phase 1 Recruiting

10 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01339988 2011-04-21

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Phase 4 Unknown

10 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Juvenile

Clinical Trials

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

PTCy and ATG for MSD and MUD Transplants

SCRIPT-AML

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)